InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Simon Douglas. Director active across 1 company, notably Fusion Antibodies plc. Aggregated, 3 reports have been recorded. History available since 4 December 2023. The latest transaction was disclosed on 22 July 2024 (Purchase). Regulator: RNS (LSE). The full history is openly available.
3 of 3 declarations